The following pages link to Survival rate
External toolsShowing 50 items.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Overall survival rate (redirect page) (links | edit)
- Male breast cancer (links | edit)
- INCTR Challenge Fund (links | edit)
- Ophioblennius atlanticus (links | edit)
- Desquamative interstitial pneumonia (links | edit)
- Defaunation (links | edit)
- Soybean aphid (links | edit)
- Springtail (links | edit)
- Disease-free survival (redirect page) (links | edit)
- DFS (links | edit)
- Index of oncology articles (links | edit)
- Aromatase inhibitor (links | edit)
- Zoledronic acid (links | edit)
- List of MeSH codes (H01) (links | edit)
- List of MeSH codes (E05) (links | edit)
- List of MeSH codes (E01) (links | edit)
- List of MeSH codes (G03) (links | edit)
- List of MeSH codes (N05) (links | edit)
- P21 (links | edit)
- DDX3X (links | edit)
- Sodium-coupled monocarboxylate transporter 1 (links | edit)
- Cure (links | edit)
- Plasmablastic lymphoma (links | edit)
- Talk:Medical terminology (links | edit)
- User:WhatamIdoing (links | edit)
- User:Louphatton/Sandbox (links | edit)
- User:Brainist/MeSH articles (links | edit)
- Cutaneous B-cell lymphoma (links | edit)
- James L. Gulley (links | edit)
- Neuroendocrine carcinoma of the cervix (links | edit)
- Thymus transplantation (links | edit)
- Brain metastasis (links | edit)
- Reperfusion therapy (links | edit)
- Nature–culture divide (links | edit)
- Sipuleucel-T (links | edit)
- Mean survival (links | edit)
- Median survival time (redirect page) (links | edit)
- Scramble competition (links | edit)
- Survival rates (redirect page) (links | edit)
- Overall survival (redirect page) (links | edit)
- Positron emission tomography (links | edit)
- Ovarian cancer (links | edit)
- Wilms' tumor (links | edit)
- Inflammatory breast cancer (links | edit)
- Small-cell carcinoma (links | edit)
- Anaplastic large-cell lymphoma (links | edit)
- Aromatase inhibitor (links | edit)
- Synovial sarcoma (links | edit)
- Lymphoid leukemia (links | edit)
- Sorafenib (links | edit)
- Aggressive fibromatosis (links | edit)
- Relative survival (links | edit)
- Transitional cell carcinoma (links | edit)
- Peginterferon alfa-2b (links | edit)
- Interferon type I (links | edit)
- Zalutumumab (links | edit)
- Vinflunine (links | edit)
- Evofosfamide (links | edit)
- Ramucirumab (links | edit)
- Pomalidomide (links | edit)
- Radium-223 (links | edit)
- Trastuzumab emtansine (links | edit)
- Yttrium (90Y) clivatuzumab tetraxetan (links | edit)
- Alternating electric field therapy (links | edit)
- Brivanib alaninate (links | edit)
- Cyproterone acetate (links | edit)
- Plasmablastic lymphoma (links | edit)
- High-dose chemotherapy and bone marrow transplant (links | edit)
- Palbociclib (links | edit)
- Tumour heterogeneity (links | edit)
- Algeta (links | edit)
- Pancreatic neuroendocrine tumor (links | edit)
- Atezolizumab (links | edit)
- FMISO (links | edit)
- PD-1 and PD-L1 inhibitors (links | edit)
- Rindopepimut (links | edit)
- Epacadostat (links | edit)
- Umbralisib (links | edit)
- High-dose estrogen therapy (links | edit)
- Comparison of bicalutamide with other antiandrogens (links | edit)
- Bland embolization (links | edit)
- Side effects of cyproterone acetate (links | edit)
- Early Prostate Cancer (clinical programme) (links | edit)
- Zabadinostat (links | edit)
- Autogene cevumeran (links | edit)
- Talk:Gemtuzumab ozogamicin (links | edit)
- Talk:Medical terminology (links | edit)
- User:Fvasconcellos/T-DM1 (links | edit)
- User:AwesomeHu/sandbox (links | edit)
- User:Azg717/sandbox (links | edit)
- Monodominance (links | edit)
- Pemphigus spyrothecae (links | edit)
- Hypodiploid acute lymphoblastic leukemia (links | edit)
- Natalobatrachus bonebergi (links | edit)
- Impact survival (links | edit)
- Irreversible electroporation (links | edit)
- Olinguito (links | edit)
- Cytoreductive surgery (links | edit)
- Q-Symbio (links | edit)
- Reticulate evolution (links | edit)
- Jessica Ainscough (links | edit)
- Axelopran (links | edit)
- Ischemic cardiomyopathy (links | edit)
- Survival (links | edit)
- Bayesian survival analysis (links | edit)
- SETD3 (gene) (links | edit)
- Paul Sugarbaker (links | edit)
- Peptide receptor radionuclide therapy (links | edit)
- GATA2 deficiency (links | edit)
- Pharmacokinetics of estradiol (links | edit)
- T cell/histiocyte-rich large B-cell lymphoma (links | edit)
- Primary testicular diffuse large B-cell lymphoma (links | edit)
- Primary cutaneous diffuse large B-cell lymphoma, leg type (links | edit)
- Diffuse large B-cell lymphoma associated with chronic inflammation (links | edit)
- Cause-specific survival (redirect to section "Cause-specific survival and disease-specific survival") (links | edit)
- Disease-specific survival (redirect to section "Cause-specific survival and disease-specific survival") (links | edit)
- Tumor mutational burden (links | edit)
- Prostate Adenocarcinoma: TransCutaneous Hormones (links | edit)